
About
Bioclonal is a biotechnology company focused on developing antibodies against challenging peptide targets, with a strong emphasis on Alzheimer’s disease. It serves pharma, biotech, and research partners from Zaragoza, Spain, and also develops products and proprietary R&D programs related to diagnostics and therapeutics.
Services
Custom antibody development
Develops custom antibodies against peptide epitopes, including project-specific strategy design, immunization, antibody generation, and initial validation for downstream applications.
Assays & in vitro testing
Monoclonal antibody characterization and production
Provides monoclonal antibody characterization and production as part of its custom development offering.
Protein production
Alzheimer antibody catalog
Offers ready-to-use research antibodies designed for Alzheimer’s research applications, including Tau and Amyloid-beta related epitopes.
Assays & in vitro testing
Proprietary Alzheimer R&D
Advances a lead program focused on pathological forms of Amyloid beta and dimeric Aβ1-42 species.
Alzheimer’s Program
Develops antibodies against pathological forms of Amyloid beta, including dimeric Aβ1-42 species.
Assays & in vitro testing
Proprietary R&D
Advances internal antibody research focused on pathological forms of Amyloid beta and related disease-relevant structures.
Capabilities
- Processes
- Antibody · Peptide · Oligonucleotide · Cell therapy · Antibodies · Peptides · ELISA · Oligonucleotides
- Capacity
- Commercial scale
Industries served
- Biotech
- Pharma
- Research
- Diagnostics
Company
- Founded
- 2022
Locations
- Based in
- Zaragoza, Spain
- Sites
- Zaragoza, Spain
- Serves
- global
Contacts
- General enquiry
- info@bioclonal.es on their site
Similar labs
Work here? Claim this listing